scispace - formally typeset
K

K. J. H. Robson

Researcher at John Radcliffe Hospital

Publications -  16
Citations -  1736

K. J. H. Robson is an academic researcher from John Radcliffe Hospital. The author has contributed to research in topics: Hemochromatosis & Genetic testing. The author has an hindex of 13, co-authored 16 publications receiving 1702 citations.

Papers
More filters
Journal ArticleDOI

Global prevalence of putative haemochromatosis mutations.

TL;DR: The distribution of the C282Y mutation coincides with that of populations in which haemochromatosis has been reported and is consistent with the theory of a north European origin for the mutation.

A simple genetic test identifies 90% of UK patients with haemochromatosis

TL;DR: In this article, the prevalence of the HLA-H associated C282Y and H63D mutations was determined by polymerase chain reaction amplification and restriction enzyme digestion in a cohort of 115 well characterised patients with GH and 101 controls from the United Kingdom.
Journal Article

A simple genetic test identifies 90% of UK patients with haemochromatosis

TL;DR: These are the first phenotypic observations for patients without either C282Y or H63D mutation of HFE, which promises to be a highly effective tool in the diagnosis of GH.
Journal ArticleDOI

The origin and spread of the HFE-C282Y haemochromatosis mutation.

TL;DR: The evidence about HFE C282Y frequencies, extended haplotypes involving HLA-A and -B alleles, the validity of calculations of mutation age, selective advantage and current views on the relative importance of “demic-diffusion” and “adoption-diffusions” in the neolithic transition in Europe and since then are examined.
Journal ArticleDOI

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

TL;DR: It is suggested that the combination of TF C2 and HFE C282Y may lead to an excess of redox-active iron and the induction of oxidative stress in neurones, which is exacerbated in carriers of APOE4.